Medicine and Dentistry
Cystic Fibrosis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Disease Exacerbation
30%
Silo-Filler's Disease
30%
Omicron Coronavirus Variant
29%
Forced Expiratory Volume
28%
Prospective Cohort Study
25%
Monoclonal Antibody Therapy
25%
Immunocompromised Patient
25%
Papillary Thyroid Cancer
25%
Predictive Factor
25%
Clinical Significance
25%
Ivacaftor
25%
Radius Fracture
25%
Compartment Syndrome
25%
Patient-Reported Outcome
25%
Numeric Rating Scale
25%
Distal Radius Fracture
25%
Randomized Controlled Trial
25%
Infection
25%
Immunoglobulin G Antibody
25%
Patient Registry
20%
Material Deprivation
16%
Monoclonal Antibody
16%
Cohort Analysis
14%
COVID-19
12%
Viral Clearance
12%
Splinting
12%
Nonunion
12%
Logistic Regression Analysis
12%
Adverse Event
12%
Odds Ratio
12%
Arm
12%
Closed Reduction (Procedure)
12%
Outpatient
9%
Monotherapy
8%
Predictor
8%
Hazard Ratio
7%
Phenotype
5%
Pancreatic Insufficiency
5%
Lung Infection
5%
Diabetes
5%
Diseases
5%
Principal Component Analysis
5%
Determinants of Health
5%
Genetic Disorder
5%
Immunology and Microbiology
COVID-19
65%
Severe Acute Respiratory Syndrome Coronavirus 2
52%
Human Immunodeficiency Virus
50%
Immunogenicity
50%
Booster Dose
50%
Spike
35%
Omicron Coronavirus Variant
29%
Monoclonal Antibody Therapy
25%
Immunocompromised Patient
25%
Alemtuzumab
25%
Kidney Graft Rejection
25%
Glucocorticoid
25%
Immunoglobulin G Antibody
25%
Monoclonal Antibody
16%
Vaccination Policy
15%
T Cell
14%
Monospecific Antibody
12%
Viral Clearance
12%
B Cell
6%
Antibody Titer
5%
Vaccine Efficacy
5%
Lymphocyte
5%
Humoral Immunity
5%
Biochemistry, Genetics and Molecular Biology
Immunogenicity
50%
Cystic Fibrosis
50%
Human Immunodeficiency Virus
50%
Spike
27%
SARS Coronavirus
27%
Ivacaftor
25%
Immunoglobulin G
25%
Forced Expiratory Volume
19%
Patient Registry
15%
Monospecific Antibody
12%
Cohort Study
10%
Messenger RNA
10%
T Cell
7%
Titer
5%
Cystic Fibrosis-Related Diabetes
5%
Humoral Immunity
5%
